GTBP GT BIOPHARMA INC Management Changes 8-K Filing 2024 - Management Change Dr. Jeffrey Miller has changed his title from Consulting Chief Medical Officer and Consulting Chief Scientific Officer to Consulting Senior Medical Director effective September 16, 2024, to align with University of Minnesota policies amid a Phase I clinical trial for GTB-3650.Get access to all SEC 8-K filings of the GT BIOPHARMA INC